Immune Monitoring During ASP2215 Therapy in Relapsed/Ref

  • He, Fiona (PI)
  • Ustun, Celalettin (Prior Principal Investigator)

Project: Research project

Project Details

Description

Immune Monitoring During ASP2215 Therapy in Relapsed/Refractory Acute Myeloid Leukemia (AML)
StatusActive
Effective start/end date5/1/163/31/21

Funding

  • Astellas Pharma US, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.